At a glance
- Originator Pharmacia Corporation
- Class Antihypertensives
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 05 Apr 2000 Monsanto has merged with Pharmacia & Upjohn to form Pharmacia Corporation
- 21 Aug 1997 Preclinical development for Hypertension in USA (PO)
- 31 Oct 1994 New profile